Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-155665
Filing Date
2004-09-13
Accepted
2004-09-13 16:19:58
Documents
8
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED JUNE 30, 2004 d10k.htm 10-K 764083
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 6003
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2154
4 SECTION 302 CEO CERTIFICATION. dex311.htm EX-31.1 6228
5 SECTION 302 CFO CERTIFICATION. dex312.htm EX-31.2 6234
6 SECTION 906 CEO CERTIFICATION. dex321.htm EX-32.1 3861
7 SECTION 906 CFO CERTIFICATION. dex322.htm EX-32.2 4110
8 GRAPHIC g51136image005.jpg GRAPHIC 109272
  Complete submission text file 0001193125-04-155665.txt   904736
Mailing Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324
Business Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 9542338377
VIRAGEN INTERNATIONAL INC (Filer) CIK: 0000785081 (see all company filings)

EIN.: 112788282 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-17827 | Film No.: 041027735
SIC: 2836 Biological Products, (No Diagnostic Substances)